Skip to main content

Table 6 Relationship between CCT2 and PDIA3 expression and clinicopathological characteristics and average survival of gallbladder AC patients

From: Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma

Clinicopathological features Case number Average survival (months) χ2 P
Gender     
male 26 9.58(3 to 24) 2.567 0.109
female 54 11.30(3 to 24)   
Age (years)     
≤ 45 16 10.81(4 to 24) 0.003 0.956
> 45 64 10.72(3 to 24)   
Degree of differentiationa     
well-differentiated 27 15.07(5 to 24)   
moderately-differentiated 25 10.60(4 to 24) 32.501 0.000
poorly-differentiated 28 6.68(3 to 14)   
Tumor maximum diameter (cm)     
≤ 3 cm 50 13.70(6 to 24) 68.283 0.000
> 3 cm 30 5.80(3 to 10)   
Gallbladder stones     
no 42 10.19(3 to 24) 0.246 0.620
yes 38 11.34(4 to 24)   
TNM stage     
I+II 21 18.96(5 to 24)   
III 38 9.29(6 to 15) 105.825 0.000
IV 21 5.14(3 to 7)   
Lymph node metastasis     
no 30 16.27(4 to 24) 42.372 0.000
yes 50 7.42(3 to 14)   
Invasion     
no 31 16.68(7 to 24) 55.535 0.000
yes 49 6.98(3 to 11)   
Surgical     
radical 26 18.31(10 to 24)   
palliative 28 8.64(6 to 11) 113.141 0.000
biopsy 26 5.42(3 to 9)   
CCT2     
- 37 13.78(6 to 24) 17.876 0.000
+ 43 8.12(3 to 24)   
PDIA3     
- 35 13.46(5 to 24) 11.604 0.001
+ 45 8.62(3 to 24)